Research

Hormonal

GLP-1 receptor agonists (semaglutide and liraglutide) are primarily requested by the public for off-label cosmetic weight loss, often without prescriptions or medical advice, creating a high risk of misuse and safety concerns.

GLP-1 medications like semaglutide and liraglutide are powerful tools for weight management and diabetes, but they are not cosmetic shortcuts. Most requests for these drugs are for weight loss without a prescription, which poses safety risks. If you are considering these medications, consult a healthcare provider to ensure they are appropriate for your health needs and to receive proper guidance on usage and side effects.

ModerateSupportsMEDIUM confidence
Requests for semaglutide and liraglutide were primarily for weight loss purposes (82.6% and 79.4%, respectively), and these agents were often sought without a prescription (over 60%) or medical recommendation (over 35%).
Dilara Bayram-Ozgur et al. · Diabetes Metabolic Syndrome and Obesity · 2026

Why this rating

Cross-sectional survey of pharmacists' perceptions and practices; not a clinical trial of the drug's efficacy.

Source

Community Pharmacists’ Knowledge and Counseling Competence on GLP-1 Receptor Agonists in Obesity and Type 2 Diabetes Care in Türkiye: A Cross-Sectional Study

Dilara Bayram-Ozgur et al. · Diabetes Metabolic Syndrome and Obesity · 2026

DOI 10.2147/dmso.s587750

cross_sectional · n=500Cited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →